Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 22, 2005
Human Molecular Genetics 2005 14(19):2829-2837; doi:10.1093/hmg/ddi315
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
14/19/2829    most recent
ddi315v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Google Scholar
Right arrow Articles by Fornage, M.
Right arrow Articles by Boerwinkle, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fornage, M.
Right arrow Articles by Boerwinkle, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact: journals.permissions@oupjournals.org

The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke

Myriam Fornage1,*, Craig R. Lee2,4, Peter A. Doris1, Molly S. Bray5, Gerardo Heiss3, Darryl C. Zeldin4 and Eric Boerwinkle1

1Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center, Houston, TX, USA, 2Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy and 3Department of Epidemiology, School of Public Health, The University of North Carolina at Chapel Hill, NC, USA, 4Division of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA and 5Department of Pediatrics, Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX, USA

* To whom correspondence should be addressed at: Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center, Houston, 2121 W. Holcombe Boulevard, Houston, TX 77030, USA. Tel: +1 7135002463; Fax: +1 7135002424; Email: myriam.fornage{at}uth.tmc.edu

Received June 23, 2005; Revised August 2, 2005; Accepted August 10, 2005

Stroke is the leading cause of severe disability and the third leading cause of death, accounting for one of every 15 deaths in the USA. We investigated the association of polymorphisms in the soluble epoxide hydrolase gene (EPHX2) with incident ischemic stroke in African-Americans and Whites. Twelve single nucleotide polymorphisms (SNPs) spanning EPHX2 were genotyped in a case-cohort sample of 1336 participants from the Atherosclerosis Risk in Communities (ARIC) study. In each racial group, Cox proportional hazard models were constructed to assess the relationship between incident ischemic stroke and EPHX2 polymorphisms. A score test method was used to investigate the association of common haplotypes of the gene with risk of ischemic stroke. In African-Americans, two common EPHX2 haplotypes with significant and opposing relationships to ischemic stroke risk were identified. In Whites, two common haplotypes showed suggestive indication of an association with ischemic stroke risk but, as in African-Americans, these relationships were in opposite direction. These findings suggest that multiple variants exist within or near the EPHX2 gene, with greatly contrasting relationships to ischemic stroke incidence; some associated with a higher incidence and others with a lower incidence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
A. N. Simpkins, R. D. Rudic, D. A. Schreihofer, S. Roy, M. Manhiani, H.-J. Tsai, B. D. Hammock, and J. D. Imig
Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection
Am. J. Pathol., June 1, 2009; 174(6): 2086 - 2095.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc GenetHome page
R. I. Dmitrieva, C. A. Hinojos, M. L. Grove, R. J. Bell, E. Boerwinkle, M. Fornage, and P. A. Doris
Genome-Wide Identification of Allelic Expression in Hypertensive Rats
Circ Cardiovasc Genet, April 1, 2009; 2(2): 106 - 115.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. J. Behm, A. Ogbonna, C. Wu, C. L. Burns-Kurtis, and S. A. Douglas
Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 231 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
K. P Burdon, A. B Lehtinen, C. D Langefeld, J. J. Carr, S. S Rich, B. I Freedman, D. Herrington, and D. W Bowden
Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study
Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 128 - 134.
[Abstract] [PDF]

Home page
 StrokeHome page
A. Gschwendtner, S. Ripke, T. Freilinger, P. Lichtner, B. Muller-Myhsok, H.-E. Wichmann, T. Meitinger, and M. Dichgans
Genetic Variation in Soluble Epoxide Hydrolase (EPHX2) Is Associated With an Increased Risk of Ischemic Stroke in White Europeans
Stroke, May 1, 2008; 39(5): 1593 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. J. Corenblum, V. E. Wise, K. Georgi, B. D. Hammock, P. A. Doris, and M. Fornage
Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat
Hypertension, February 1, 2008; 51(2): 567 - 573.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
I. P. Koerner, R. Jacks, A. E. DeBarber, D. Koop, P. Mao, D. F. Grant, and N. J. Alkayed
Polymorphisms in the Human Soluble Epoxide Hydrolase Gene EPHX2 Linked to Neuronal Survival after Ischemic Injury
J. Neurosci., April 25, 2007; 27(17): 4642 - 4649.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. R. Lee, K. E. North, M. S. Bray, M. Fornage, J. M. Seubert, J. W. Newman, B. D. Hammock, D. J. Couper, G. Heiss, and D. C. Zeldin
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
Hum. Mol. Genet., May 15, 2006; 15(10): 1640 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
T. Pastinen, B. Ge, S. Gurd, T. Gaudin, C. Dore, M. Lemire, P. Lepage, E. Harmsen, and T. J. Hudson
Mapping common regulatory variants to human haplotypes
Hum. Mol. Genet., December 15, 2005; 14(24): 3963 - 3971.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.